Study of Stapokibart Injection in Subjects With Moderate to Severe Bullous Pemphigoid
Clinical trial NCT07210554 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07210554
- Sponsor
- Chengdu Kangnuoxing Biopharma,Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-11
- Primary completion
- 2028-03-27
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.